Literature DB >> 35405068

Discovery of a Cyclic Cell-Penetrating Peptide with Improved Endosomal Escape and Cytosolic Delivery Efficiency.

Marina Buyanova1, Ashweta Sahni1, Rui Yang1, Amar Sarkar1, Heba Salim1, Dehua Pei1.   

Abstract

Cyclic cell-penetrating peptide 12 (CPP12) is highly efficient for the cytosolic delivery of a variety of cargo molecules into mammalian cells in vitro and in vivo. However, its cytosolic entry efficiency is substantially reduced at lower concentrations or in the presence of serum proteins. In this study, CPP12 analogs were prepared by replacing its hydrophobic residues with amino acids of varying hydrophobicity and evaluated for cellular entry. Substitution of l-3-benzothienylalanine (Bta) for l-2-naphthylalanine (Nal) resulted in CPP12-2, which exhibits up to 3.8-fold higher cytosolic entry efficiency than CPP12, especially at low CPP concentrations; thanks to improved endosomal escape efficiency. CPP12-2 is well suited for the cytosolic delivery of highly potent cargos to achieve biological activity at low concentrations.

Entities:  

Keywords:  cell-penetrating peptide; drug delivery; endosomal escape; intracellular biologics; peptide therapeutics

Mesh:

Substances:

Year:  2022        PMID: 35405068      PMCID: PMC9175492          DOI: 10.1021/acs.molpharmaceut.1c00924

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   5.364


  44 in total

1.  A peptide carrier for the delivery of biologically active proteins into mammalian cells.

Authors:  M C Morris; J Depollier; J Mery; F Heitz; G Divita
Journal:  Nat Biotechnol       Date:  2001-12       Impact factor: 54.908

2.  The pharmacokinetics of cell-penetrating peptides.

Authors:  Dikran Sarko; Barbro Beijer; Regine Garcia Boy; Eva-Maria Nothelfer; Karin Leotta; Michael Eisenhut; Annette Altmann; Uwe Haberkorn; Walter Mier
Journal:  Mol Pharm       Date:  2010-10-07       Impact factor: 4.939

3.  Tuning the properties of a novel short cell-penetrating peptide by intramolecular cyclization with a triazole bridge.

Authors:  M Horn; F Reichart; S Natividad-Tietz; D Diaz; I Neundorf
Journal:  Chem Commun (Camb)       Date:  2016-02-07       Impact factor: 6.222

Review 4.  Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.

Authors:  Bhawna Gupta; Tatiana S Levchenko; Vladimir P Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2004-12-22       Impact factor: 15.470

5.  Cell-permeable nanobodies for targeted immunolabelling and antigen manipulation in living cells.

Authors:  Henry D Herce; Dominik Schumacher; Anselm F L Schneider; Anne K Ludwig; Florian A Mann; Marion Fillies; Marc-André Kasper; Stefan Reinke; Eberhard Krause; Heinrich Leonhardt; M Cristina Cardoso; Christian P R Hackenberger
Journal:  Nat Chem       Date:  2017-07-17       Impact factor: 24.427

6.  Development of a Cell-Permeable Cyclic Peptidyl Inhibitor against the Keap1-Nrf2 Interaction.

Authors:  Heba Salim; Jian Song; Ashweta Sahni; Dehua Pei
Journal:  J Org Chem       Date:  2019-10-28       Impact factor: 4.354

7.  Targeted Subcellular Protein Delivery Using Cleavable Cyclic Cell-Penetrating Peptides.

Authors:  Anselm F L Schneider; Antoine L D Wallabregue; Luise Franz; Christian P R Hackenberger
Journal:  Bioconjug Chem       Date:  2019-01-14       Impact factor: 4.774

8.  An intracellular nanobody targeting T4SS effector inhibits Ehrlichia infection.

Authors:  Wenqing Zhang; Mingqun Lin; Qi Yan; Khemraj Budachetri; Libo Hou; Ashweta Sahni; Hongyan Liu; Nien-Ching Han; Jeffrey Lakritz; Dehua Pei; Yasuko Rikihisa
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

9.  Backbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptides.

Authors:  Gisela Lättig-Tünnemann; Manuel Prinz; Daniel Hoffmann; Joachim Behlke; Caroline Palm-Apergi; Ingo Morano; Henry D Herce; M Cristina Cardoso
Journal:  Nat Commun       Date:  2011-08-30       Impact factor: 14.919

10.  Enhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics.

Authors:  Peter Lönn; Apollo D Kacsinta; Xian-Shu Cui; Alexander S Hamil; Manuel Kaulich; Khirud Gogoi; Steven F Dowdy
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

View more
  1 in total

Review 1.  Overcoming the cellular barriers and beyond: Recent progress on cell penetrating peptide modified nanomedicine in combating physiological and pathological barriers.

Authors:  Yingke Liu; Zhihe Zhao; Man Li
Journal:  Asian J Pharm Sci       Date:  2022-06-23       Impact factor: 9.273

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.